Validity of Endoscopic Submucosal Dissection for Gastric Cancer Diagnosed as Differentiated Adenocarcinoma Before Treatment Regardless of Lesion Size
Turkish Journal of Gastroenterology · 2023
DOI: 10.5152/tjg.2023.22611 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Gastroenterology, 2023. Verfasst von Kosuke Nomura und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Toranomon Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Stomach Neoplasms, Endoscopic Mucosal Resection, Gastroparesis, Adenocarcinoma. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background/Aims: We investigated the validity and safety of endoscopic submucosal dissection for gastric tumors by examining shortand long-term outcomes by tumor diameter. Materials and Methods: Endoscopic submucosal dissection for gastric tumor was performed on 4259 lesions at our hospital between January 2005 and June 2021. [Study 1] Patients were divided into 5 tumor diameter groups: 3751 lesions, ≤30 mm; 366 lesions, 31-50 mm; 106 lesions, 51-75 mm; 24 lesions, 76-100 mm; and 12 lesions, ≥101 mm. Short-term gastric endoscopic submucosal dissection outcomes were investigated. [Study 2] Long-term outcomes (delayed gastric emptying and prognosis) were investigated in 508 cases with tumor diameter ≥31 mm. Results: [Study 1] Perforation rate (%) was 1.2, 3.6, 3.8, 12.5, and 25.0 for lesions with tumor diameter ≤30 mm, in the range 31-50 mm, 51-75 mm, and 76-100 mm, and ≥101 mm, respectively. Postoperative bleeding rate (%) was 4.8, 9.0, 6.6, 20.8, and 33.3, respectively, R0 resection rate (%) was 96.8, 90.2, 89.6, 70.8, and 66.6, respectively, and curative resection rate (%) was 92.0, 61.2, 63.2, 45.8, and 8.3, respectively. [Study 2] There were 7 cases of delayed gastric emptying after wide resection, with 3 patients requiring balloon dilatation, 1 of whom subsequently underwent distal gastrectomy. Among 205 cases of noncurative resection, 110 underwent additional surgery, residual cancer was present in 11 cases, and lymph node metastasis was observed in 7 cases (1 patient died of disease). To date, 1 of the 95 patients being followed up has died of disease (mean follow-up: 2042 days). Conclusion: Even with a tumor diameter ≥31 mm, curative resection was achieved in about 60% of cases in which intramucosal lesions were considered possible preoperatively, but the rate was low at 8.3% for tumor diameter ≥101 mm. Long-term outcomes appear favorable, with only 0.4% of the patients dying of disease but delayed gastric emptying observed in 1.7% of cases. Cite this article as: Nomura K, Hoteya S, Ochiai Y, et al. Validity of endoscopic submucosal dissection for gastric cancer diagnosed as differentiated adenocarcinoma before treatment regardless of lesion size. Turk J Gastroenterol. 2023;34(11):1143-1149.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Gastroenterology, Toranomon Hospital, Tokyo, Japan.
Zitieren
APA
Nomura, K., Hoteya, S., Ochiai, Y., Okamura, T., Suzuki, Y., Hayasaka, J., Mitsunaga, Y., Tanaka, M., Fuchinoue, K., Odagiri, H., Yamashita, S., Matsui, A., & Kikuchi, D. (2023). Validity of Endoscopic Submucosal Dissection for Gastric Cancer Diagnosed as Differentiated Adenocarcinoma Before Treatment Regardless of Lesion Size. Turkish Journal of Gastroenterology. https://doi.org/10.5152/tjg.2023.22611
Vancouver
Nomura K, Hoteya S, Ochiai Y, Okamura T, Suzuki Y, Hayasaka J, et al. Validity of Endoscopic Submucosal Dissection for Gastric Cancer Diagnosed as Differentiated Adenocarcinoma Before Treatment Regardless of Lesion Size. Turkish Journal of Gastroenterology. 2023. doi:10.5152/tjg.2023.22611
BibTeX
@article{Nomura2023,
author = {Nomura, Kosuke and Hoteya, Shu and Ochiai, Yorinari and Okamura, Takayuki and Suzuki, Yugo and Hayasaka, Junnosuke and Mitsunaga, Yutaka and Tanaka, Masami and Fuchinoue, Kazuhiro and Odagiri, Hiroyuki and Yamashita, Satoshi and Matsui, Akira and Kikuchi, Daisuke},
title = {Validity of Endoscopic Submucosal Dissection for Gastric Cancer Diagnosed as Differentiated Adenocarcinoma Before Treatment Regardless of Lesion Size},
journal = {Turkish Journal of Gastroenterology},
year = {2023},
doi = {10.5152/tjg.2023.22611}
}
EUVIMED